summary,summary_detail,id,guidislink,links,url,date,published_parsed,title,title_detail,ticker,source,text,Year,Month,Day,Weekday,text_length,word_count,title_length,title_word_count
Both ABBV and MRK are leading pharmaceutical companies with strong portfolios in oncology and immunology.,"{'type': 'text/html', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=MRK&region=US&lang=en-US', 'value': 'Both ABBV and MRK are leading pharmaceutical companies with strong portfolios in oncology and immunology.'}",32be8d4c-5a1f-3cbc-886f-6230fb48cd47,False,"[{'rel': 'alternate', 'type': 'text/html', 'href': 'https://finance.yahoo.com/news/abbv-vs-mrk-drug-giant-143700084.html?.tsrc=rss'}]",https://finance.yahoo.com/news/abbv-vs-mrk-drug-giant-143700084.html?.tsrc=rss,2025-04-14 14:37:00,"time.struct_time(tm_year=2025, tm_mon=4, tm_mday=14, tm_hour=14, tm_min=37, tm_sec=0, tm_wday=0, tm_yday=104, tm_isdst=0)",ABBV vs. MRK: Which Drug Giant is a Better Buy Now?,"{'type': 'text/plain', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=MRK&region=US&lang=en-US', 'value': 'ABBV vs. MRK: Which Drug Giant is a Better Buy Now?'}",MRK,Yahoo Finance,ABBV vs. MRK: Which Drug Giant is a Better Buy Now? Both ABBV and MRK are leading pharmaceutical companies with strong portfolios in oncology and immunology.,2025,4,14,0,157,26,51,11
"We recently published a list of the 11 Cheap NYSE Stocks to Invest in According to Hedge Funds. In this article, we are going to take a look at where Merck & Co. (NYSE:MRK) stands against other cheap NYSE stocks. On March 26, Jack Caffrey of JPMorgan Asset Management provided an analysis of market trends […]","{'type': 'text/html', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=MRK&region=US&lang=en-US', 'value': 'We recently published a list of the 11 Cheap NYSE Stocks to Invest in According to Hedge Funds. In this article, we are going to take a look at where Merck & Co. (NYSE:MRK) stands against other cheap NYSE stocks. On March 26, Jack Caffrey of JPMorgan Asset Management provided an analysis of market trends […]'}",5829b0be-eea9-3e6a-a936-bec743d890d7,False,"[{'rel': 'alternate', 'type': 'text/html', 'href': 'https://finance.yahoo.com/news/merck-co-nyse-mrk-cheap-142910051.html?.tsrc=rss'}]",https://finance.yahoo.com/news/merck-co-nyse-mrk-cheap-142910051.html?.tsrc=rss,2025-04-14 14:29:10,"time.struct_time(tm_year=2025, tm_mon=4, tm_mday=14, tm_hour=14, tm_min=29, tm_sec=10, tm_wday=0, tm_yday=104, tm_isdst=0)",Is Merck & Co. (NYSE:MRK) a Cheap NYSE Stock to Invest in According to Hedge Funds?,"{'type': 'text/plain', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=MRK&region=US&lang=en-US', 'value': 'Is Merck & Co. (NYSE:MRK) a Cheap NYSE Stock to Invest in According to Hedge Funds?'}",MRK,Yahoo Finance,"Is Merck & Co. (NYSE:MRK) a Cheap NYSE Stock to Invest in According to Hedge Funds? We recently published a list of the 11 Cheap NYSE Stocks to Invest in According to Hedge Funds. In this article, we are going to take a look at where Merck & Co. (NYSE:MRK) stands against other cheap NYSE stocks. On March 26, Jack Caffrey of JPMorgan Asset Management provided an analysis of market trends […]",2025,4,14,0,393,72,83,16
"We recently published a list of 10 Best Medical Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other best medical stocks to buy according to billionaires. Why are Healthcare Stocks Under Pressure? Some experts view medical, healthcare, and […]","{'type': 'text/html', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=MRK&region=US&lang=en-US', 'value': 'We recently published a list of 10 Best Medical Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other best medical stocks to buy according to billionaires. Why are Healthcare Stocks Under Pressure? Some experts view medical, healthcare, and […]'}",399bacf6-6e50-3be6-926b-83b2513ce537,False,"[{'rel': 'alternate', 'type': 'text/html', 'href': 'https://finance.yahoo.com/news/merck-co-inc-mrk-best-215759150.html?.tsrc=rss'}]",https://finance.yahoo.com/news/merck-co-inc-mrk-best-215759150.html?.tsrc=rss,2025-04-13 21:57:59,"time.struct_time(tm_year=2025, tm_mon=4, tm_mday=13, tm_hour=21, tm_min=57, tm_sec=59, tm_wday=6, tm_yday=103, tm_isdst=0)","Is Merck & Co., Inc. (MRK) the Best Medical Stock to Buy According to Billionaires?","{'type': 'text/plain', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=MRK&region=US&lang=en-US', 'value': 'Is Merck & Co., Inc. (MRK) the Best Medical Stock to Buy According to Billionaires?'}",MRK,Yahoo Finance,"Is Merck & Co., Inc. (MRK) the Best Medical Stock to Buy According to Billionaires? We recently published a list of 10 Best Medical Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other best medical stocks to buy according to billionaires. Why are Healthcare Stocks Under Pressure? Some experts view medical, healthcare, and […]",2025,4,13,6,419,71,83,15
"We recently published a list of Jim Cramer Recently Talked About These 9 Stocks. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE: MRK) stands against other stocks that Jim Cramer discussed recently. On Wednesday, Jim Cramer, the host of Mad Money, shared his thoughts on the […]","{'type': 'text/html', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=MRK&region=US&lang=en-US', 'value': 'We recently published a list of Jim Cramer Recently Talked About These 9 Stocks. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE: MRK) stands against other stocks that Jim Cramer discussed recently. On Wednesday, Jim Cramer, the host of Mad Money, shared his thoughts on the […]'}",87d3ee81-4e05-3a55-901d-ef8152420f1a,False,"[{'rel': 'alternate', 'type': 'text/html', 'href': 'https://finance.yahoo.com/news/jim-cramer-merck-mrk-stay-163345390.html?.tsrc=rss'}]",https://finance.yahoo.com/news/jim-cramer-merck-mrk-stay-163345390.html?.tsrc=rss,2025-04-11 16:33:45,"time.struct_time(tm_year=2025, tm_mon=4, tm_mday=11, tm_hour=16, tm_min=33, tm_sec=45, tm_wday=4, tm_yday=101, tm_isdst=0)",Jim Cramer on Merck (MRK): Stay The Course… It’s Been a Real Tough One,"{'type': 'text/plain', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=MRK&region=US&lang=en-US', 'value': 'Jim Cramer on Merck (MRK): Stay The Course… It’s Been a Real Tough One'}",MRK,Yahoo Finance,"Jim Cramer on Merck (MRK): Stay The Course… It’s Been a Real Tough One We recently published a list of Jim Cramer Recently Talked About These 9 Stocks. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE: MRK) stands against other stocks that Jim Cramer discussed recently. On Wednesday, Jim Cramer, the host of Mad Money, shared his thoughts on the […]",2025,4,11,4,379,70,70,14
"Merck (NYSE:MRK) recently experienced a significant corporate governance event when multiple shareholder proposals were announced, with the company recommending against them for the upcoming annual meeting. This development comes amid a general market downturn, underscored by the Dow and Nasdaq dropping 4% and 6%, respectively. Over the past week, Merck's share price has decreased by 5.42%, slightly exceeding the broader market's decline. The combination of these shareholder proposals and...","{'type': 'text/html', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=MRK&region=US&lang=en-US', 'value': ""Merck (NYSE:MRK) recently experienced a significant corporate governance event when multiple shareholder proposals were announced, with the company recommending against them for the upcoming annual meeting. This development comes amid a general market downturn, underscored by the Dow and Nasdaq dropping 4% and 6%, respectively. Over the past week, Merck's share price has decreased by 5.42%, slightly exceeding the broader market's decline. The combination of these shareholder proposals and...""}",ec0da42a-1d30-3d09-b5c1-9c2aa3a210a4,False,"[{'rel': 'alternate', 'type': 'text/html', 'href': 'https://finance.yahoo.com/news/merck-nyse-mrk-faces-multiple-172317255.html?.tsrc=rss'}]",https://finance.yahoo.com/news/merck-nyse-mrk-faces-multiple-172317255.html?.tsrc=rss,2025-04-10 17:23:17,"time.struct_time(tm_year=2025, tm_mon=4, tm_mday=10, tm_hour=17, tm_min=23, tm_sec=17, tm_wday=3, tm_yday=100, tm_isdst=0)",Merck (NYSE:MRK) Faces Multiple Shareholder Proposals Ahead Of Annual Meeting,"{'type': 'text/plain', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=MRK&region=US&lang=en-US', 'value': 'Merck (NYSE:MRK) Faces Multiple Shareholder Proposals Ahead Of Annual Meeting'}",MRK,Yahoo Finance,"Merck (NYSE:MRK) Faces Multiple Shareholder Proposals Ahead Of Annual Meeting Merck (NYSE:MRK) recently experienced a significant corporate governance event when multiple shareholder proposals were announced, with the company recommending against them for the upcoming annual meeting. This development comes amid a general market downturn, underscored by the Dow and Nasdaq dropping 4% and 6%, respectively. Over the past week, Merck's share price has decreased by 5.42%, slightly exceeding the broader market's decline. The combination of these shareholder proposals and...",2025,4,10,3,574,79,77,10
Pharma stocks tumbled Thursday after the Trump administration said the delay for reciprocal tariffs doesn't apply to sector-specific tariffs.,"{'type': 'text/html', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=MRK&region=US&lang=en-US', 'value': ""Pharma stocks tumbled Thursday after the Trump administration said the delay for reciprocal tariffs doesn't apply to sector-specific tariffs.""}",5788e167-ba2e-3f2d-8e9e-4bfb72e0e2c1,False,"[{'rel': 'alternate', 'type': 'text/html', 'href': 'https://finance.yahoo.com/m/5788e167-ba2e-3f2d-8e9e-4bfb72e0e2c1/s%26p%2C-dow-jones-pharma-names.html?.tsrc=rss'}]",https://finance.yahoo.com/m/5788e167-ba2e-3f2d-8e9e-4bfb72e0e2c1/s%26p%2C-dow-jones-pharma-names.html?.tsrc=rss,2025-04-10 16:58:23,"time.struct_time(tm_year=2025, tm_mon=4, tm_mday=10, tm_hour=16, tm_min=58, tm_sec=23, tm_wday=3, tm_yday=100, tm_isdst=0)","S&P, Dow Jones Pharma Names Rattled — Again — On Trump's Tariffs Whiplash","{'type': 'text/plain', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=MRK&region=US&lang=en-US', 'value': ""S&P, Dow Jones Pharma Names Rattled — Again — On Trump's Tariffs Whiplash""}",MRK,Yahoo Finance,"S&P, Dow Jones Pharma Names Rattled — Again — On Trump's Tariffs Whiplash Pharma stocks tumbled Thursday after the Trump administration said the delay for reciprocal tariffs doesn't apply to sector-specific tariffs.",2025,4,10,3,215,32,73,13
"We came across a bullish thesis on Merck & Co., Inc. (MRK) on Substack by Charly AI. In this article, we will summarize the bulls’ thesis on MRK. Merck & Co., Inc. (MRK)’s share was trading at $81.91 as of April 9th. MRK’s trailing and forward P/E were 12.15 and 9.10 respectively according to Yahoo Finance. Merck […]","{'type': 'text/html', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=MRK&region=US&lang=en-US', 'value': 'We came across a bullish thesis on Merck & Co., Inc. (MRK) on Substack by Charly AI. In this article, we will summarize the bulls’ thesis on MRK. Merck & Co., Inc. (MRK)’s share was trading at $81.91 as of April 9th. MRK’s trailing and forward P/E were 12.15 and 9.10 respectively according to Yahoo Finance. Merck […]'}",3680ca98-ebf8-37ec-b129-d0888deb81ab,False,"[{'rel': 'alternate', 'type': 'text/html', 'href': 'https://finance.yahoo.com/news/merck-co-inc-mrk-bull-125550249.html?.tsrc=rss'}]",https://finance.yahoo.com/news/merck-co-inc-mrk-bull-125550249.html?.tsrc=rss,2025-04-10 12:55:50,"time.struct_time(tm_year=2025, tm_mon=4, tm_mday=10, tm_hour=12, tm_min=55, tm_sec=50, tm_wday=3, tm_yday=100, tm_isdst=0)","Merck & Co., Inc. (MRK): A Bull Case Theory","{'type': 'text/plain', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=MRK&region=US&lang=en-US', 'value': 'Merck & Co., Inc. (MRK): A Bull Case Theory'}",MRK,Yahoo Finance,"Merck & Co., Inc. (MRK): A Bull Case Theory We came across a bullish thesis on Merck & Co., Inc. (MRK) on Substack by Charly AI. In this article, we will summarize the bulls’ thesis on MRK. Merck & Co., Inc. (MRK)’s share was trading at $81.91 as of April 9th. MRK’s trailing and forward P/E were 12.15 and 9.10 respectively according to Yahoo Finance. Merck […]",2025,4,10,3,362,67,43,9
"Catalysts host Madison Mills and Trader Talk podcast host Kenny Polcari take a look at some of the day's top trending stocks. Apple (AAPL) is in focus after Microsoft (MSFT) replaced Apple as the most valuable company. Alibaba (BABA) reverses earlier gains after US tariffs went into effect. Drugmaker stocks, including Pfizer (PFE), Merck (MRK), and Eli Lilly (LLY), are falling after President Trump announced that pharmaceutical tariffs may be on the way. To watch more expert insights and analysis on the latest market action, check out more Catalysts here.","{'type': 'text/html', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=MRK&region=US&lang=en-US', 'value': ""Catalysts host Madison Mills and Trader Talk podcast host Kenny Polcari take a look at some of the day's top trending stocks. Apple (AAPL) is in focus after Microsoft (MSFT) replaced Apple as the most valuable company. Alibaba (BABA) reverses earlier gains after US tariffs went into effect. Drugmaker stocks, including Pfizer (PFE), Merck (MRK), and Eli Lilly (LLY), are falling after President Trump announced that pharmaceutical tariffs may be on the way. To watch more expert insights and analysis on the latest market action, check out more Catalysts here.""}",22407950-a8f9-3d18-b6ce-42a8911228cd,False,"[{'rel': 'alternate', 'type': 'text/html', 'href': 'https://finance.yahoo.com/video/apple-alibaba-drugmaker-stocks-trending-144322260.html?.tsrc=rss'}]",https://finance.yahoo.com/video/apple-alibaba-drugmaker-stocks-trending-144322260.html?.tsrc=rss,2025-04-09 14:43:22,"time.struct_time(tm_year=2025, tm_mon=4, tm_mday=9, tm_hour=14, tm_min=43, tm_sec=22, tm_wday=2, tm_yday=99, tm_isdst=0)","Apple, Alibaba, drugmaker stocks: Trending Tickers","{'type': 'text/plain', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=MRK&region=US&lang=en-US', 'value': 'Apple, Alibaba, drugmaker stocks: Trending Tickers'}",MRK,Yahoo Finance,"Apple, Alibaba, drugmaker stocks: Trending Tickers Catalysts host Madison Mills and Trader Talk podcast host Kenny Polcari take a look at some of the day's top trending stocks. Apple (AAPL) is in focus after Microsoft (MSFT) replaced Apple as the most valuable company. Alibaba (BABA) reverses earlier gains after US tariffs went into effect. Drugmaker stocks, including Pfizer (PFE), Merck (MRK), and Eli Lilly (LLY), are falling after President Trump announced that pharmaceutical tariffs may be on the way. To watch more expert insights and analysis on the latest market action, check out more Catalysts here.",2025,4,9,2,612,96,50,6
"Drugmaker stocks, including Eli Lilly (LLY), Johnson & Johnson (JNJ), Merck (MRK), and Pfizer (PFE), are under pressure on Wednesday after President Trump announced that he may impose tariffs on pharmaceutical imports. Yahoo Finance Senior Health Reporter Anjalee Khemlani joins Morning Brief to break down the details. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.","{'type': 'text/html', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=MRK&region=US&lang=en-US', 'value': 'Drugmaker stocks, including Eli Lilly (LLY), Johnson & Johnson (JNJ), Merck (MRK), and Pfizer (PFE), are under pressure on Wednesday after President Trump announced that he may impose tariffs on pharmaceutical imports. Yahoo Finance Senior Health Reporter Anjalee Khemlani joins Morning Brief to break down the details. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.'}",42788375-b286-39dd-b048-683f4aab07b7,False,"[{'rel': 'alternate', 'type': 'text/html', 'href': 'https://finance.yahoo.com/video/trump-says-pharmaceutical-tariffs-may-141157823.html?.tsrc=rss'}]",https://finance.yahoo.com/video/trump-says-pharmaceutical-tariffs-may-141157823.html?.tsrc=rss,2025-04-09 14:11:57,"time.struct_time(tm_year=2025, tm_mon=4, tm_mday=9, tm_hour=14, tm_min=11, tm_sec=57, tm_wday=2, tm_yday=99, tm_isdst=0)",Trump says pharmaceutical tariffs may be coming: What to know,"{'type': 'text/plain', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=MRK&region=US&lang=en-US', 'value': 'Trump says pharmaceutical tariffs may be coming: What to know'}",MRK,Yahoo Finance,"Trump says pharmaceutical tariffs may be coming: What to know Drugmaker stocks, including Eli Lilly (LLY), Johnson & Johnson (JNJ), Merck (MRK), and Pfizer (PFE), are under pressure on Wednesday after President Trump announced that he may impose tariffs on pharmaceutical imports. Yahoo Finance Senior Health Reporter Anjalee Khemlani joins Morning Brief to break down the details. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.",2025,4,9,2,488,75,61,10
"Pharma names whipsawed Wednesday after Trump said he would enact ""major"" tariffs on drug imports and then backed off his tariffs — for now.","{'type': 'text/html', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=MRK&region=US&lang=en-US', 'value': 'Pharma names whipsawed Wednesday after Trump said he would enact ""major"" tariffs on drug imports and then backed off his tariffs — for now.'}",be7d1b24-7c1e-38ff-91b2-281ea7807568,False,"[{'rel': 'alternate', 'type': 'text/html', 'href': 'https://finance.yahoo.com/m/be7d1b24-7c1e-38ff-91b2-281ea7807568/dow-jones%2C-s%26p-500-pharma.html?.tsrc=rss'}]",https://finance.yahoo.com/m/be7d1b24-7c1e-38ff-91b2-281ea7807568/dow-jones%2C-s%26p-500-pharma.html?.tsrc=rss,2025-04-09 14:06:24,"time.struct_time(tm_year=2025, tm_mon=4, tm_mday=9, tm_hour=14, tm_min=6, tm_sec=24, tm_wday=2, tm_yday=99, tm_isdst=0)","Dow Jones, S&P 500 Pharma Names Recover After Trump Backs Off His Tariffs Plan","{'type': 'text/plain', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=MRK&region=US&lang=en-US', 'value': 'Dow Jones, S&P 500 Pharma Names Recover After Trump Backs Off His Tariffs Plan'}",MRK,Yahoo Finance,"Dow Jones, S&P 500 Pharma Names Recover After Trump Backs Off His Tariffs Plan Pharma names whipsawed Wednesday after Trump said he would enact ""major"" tariffs on drug imports and then backed off his tariffs — for now.",2025,4,9,2,218,38,78,14
"Trump tariff news: President Trump's latest tariffs took effect Wednesday while China stepped up retaliation. Treasury yields are worrisome. Walmart and Delta Air pulled some guidance, citing tariff uncertainty.","{'type': 'text/html', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=MRK&region=US&lang=en-US', 'value': ""Trump tariff news: President Trump's latest tariffs took effect Wednesday while China stepped up retaliation. Treasury yields are worrisome. Walmart and Delta Air pulled some guidance, citing tariff uncertainty.""}",a3b4073e-cf6b-3c9f-8915-5acaa3968de0,False,"[{'rel': 'alternate', 'type': 'text/html', 'href': 'https://finance.yahoo.com/m/a3b4073e-cf6b-3c9f-8915-5acaa3968de0/trump-tariff-news%3A-new.html?.tsrc=rss'}]",https://finance.yahoo.com/m/a3b4073e-cf6b-3c9f-8915-5acaa3968de0/trump-tariff-news%3A-new.html?.tsrc=rss,2025-04-09 13:57:49,"time.struct_time(tm_year=2025, tm_mon=4, tm_mday=9, tm_hour=13, tm_min=57, tm_sec=49, tm_wday=2, tm_yday=99, tm_isdst=0)","Trump Tariff News: New Tariffs Begin, China Retaliates; Treasury Yields Spike While Delta, Walmart Pull Guidance","{'type': 'text/plain', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=MRK&region=US&lang=en-US', 'value': 'Trump Tariff News: New Tariffs Begin, China Retaliates; Treasury Yields Spike While Delta, Walmart Pull Guidance'}",MRK,Yahoo Finance,"Trump Tariff News: New Tariffs Begin, China Retaliates; Treasury Yields Spike While Delta, Walmart Pull Guidance Trump tariff news: President Trump's latest tariffs took effect Wednesday while China stepped up retaliation. Treasury yields are worrisome. Walmart and Delta Air pulled some guidance, citing tariff uncertainty.",2025,4,9,2,324,45,112,16
"We recently published a list of 10 Defensive Stocks Billionaire Ken Fisher is Betting On. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other defensive stocks billionaire Ken Fisher is betting on. Ken Fisher, an American billionaire investor, author, and financial analyst, founded and runs Fisher […]","{'type': 'text/html', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=MRK&region=US&lang=en-US', 'value': 'We recently published a list of 10 Defensive Stocks Billionaire Ken Fisher is Betting On. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other defensive stocks billionaire Ken Fisher is betting on. Ken Fisher, an American billionaire investor, author, and financial analyst, founded and runs Fisher […]'}",5992a3b0-052f-3a00-9b42-f2b413b30595,False,"[{'rel': 'alternate', 'type': 'text/html', 'href': 'https://finance.yahoo.com/news/merck-co-inc-mrk-among-221507847.html?.tsrc=rss'}]",https://finance.yahoo.com/news/merck-co-inc-mrk-among-221507847.html?.tsrc=rss,2025-04-08 22:15:07,"time.struct_time(tm_year=2025, tm_mon=4, tm_mday=8, tm_hour=22, tm_min=15, tm_sec=7, tm_wday=1, tm_yday=98, tm_isdst=0)","Merck & Co., Inc. (MRK): Among Defensive Stocks Billionaire Ken Fisher is Betting On","{'type': 'text/plain', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=MRK&region=US&lang=en-US', 'value': 'Merck & Co., Inc. (MRK): Among Defensive Stocks Billionaire Ken Fisher is Betting On'}",MRK,Yahoo Finance,"Merck & Co., Inc. (MRK): Among Defensive Stocks Billionaire Ken Fisher is Betting On We recently published a list of 10 Defensive Stocks Billionaire Ken Fisher is Betting On. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other defensive stocks billionaire Ken Fisher is betting on. Ken Fisher, an American billionaire investor, author, and financial analyst, founded and runs Fisher […]",2025,4,8,1,438,72,84,14
"Walgreens (WBA) stock is rising after the company reported better-than-expected second quarter earnings while preparing for privatization. Yahoo Finance Senior Health Reporter Anjalee Khemlani highlights the company's cost management strategy, CVS's (CVS) leadership changes amid similar challenges in the retail drug sector, and moves by US drug makers, like Merck (MRK), Johnson & Johnson (JNJ), and Eli Lilly (LLY), as they prepare for incoming tariffs. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.","{'type': 'text/html', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=MRK&region=US&lang=en-US', 'value': ""Walgreens (WBA) stock is rising after the company reported better-than-expected second quarter earnings while preparing for privatization. Yahoo Finance Senior Health Reporter Anjalee Khemlani highlights the company's cost management strategy, CVS's (CVS) leadership changes amid similar challenges in the retail drug sector, and moves by US drug makers, like Merck (MRK), Johnson & Johnson (JNJ), and Eli Lilly (LLY), as they prepare for incoming tariffs. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.""}",a4b082d4-d3e5-3d1d-8c66-df0c01b86afc,False,"[{'rel': 'alternate', 'type': 'text/html', 'href': 'https://finance.yahoo.com/video/walgreens-cvs-us-drugmakers-big-140318681.html?.tsrc=rss'}]",https://finance.yahoo.com/video/walgreens-cvs-us-drugmakers-big-140318681.html?.tsrc=rss,2025-04-08 14:03:18,"time.struct_time(tm_year=2025, tm_mon=4, tm_mday=8, tm_hour=14, tm_min=3, tm_sec=18, tm_wday=1, tm_yday=98, tm_isdst=0)","Walgreens, CVS, & US drugmakers make big moves: What to know","{'type': 'text/plain', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=MRK&region=US&lang=en-US', 'value': 'Walgreens, CVS, & US drugmakers make big moves: What to know'}",MRK,Yahoo Finance,"Walgreens, CVS, & US drugmakers make big moves: What to know Walgreens (WBA) stock is rising after the company reported better-than-expected second quarter earnings while preparing for privatization. Yahoo Finance Senior Health Reporter Anjalee Khemlani highlights the company's cost management strategy, CVS's (CVS) leadership changes amid similar challenges in the retail drug sector, and moves by US drug makers, like Merck (MRK), Johnson & Johnson (JNJ), and Eli Lilly (LLY), as they prepare for incoming tariffs. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.",2025,4,8,1,624,94,60,11
"Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Organon (NYSE:OGN) and the best and worst performers in the branded pharmaceuticals industry.","{'type': 'text/html', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=MRK&region=US&lang=en-US', 'value': 'Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Organon (NYSE:OGN) and the best and worst performers in the branded pharmaceuticals industry.'}",cdc5860f-4d10-3f55-9797-9bc389b535f2,False,"[{'rel': 'alternate', 'type': 'text/html', 'href': 'https://finance.yahoo.com/news/q4-earnings-roundup-organon-nyse-090718154.html?.tsrc=rss'}]",https://finance.yahoo.com/news/q4-earnings-roundup-organon-nyse-090718154.html?.tsrc=rss,2025-04-08 09:07:18,"time.struct_time(tm_year=2025, tm_mon=4, tm_mday=8, tm_hour=9, tm_min=7, tm_sec=18, tm_wday=1, tm_yday=98, tm_isdst=0)",Q4 Earnings Roundup: Organon (NYSE:OGN) And The Rest Of The Branded Pharmaceuticals Segment,"{'type': 'text/plain', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=MRK&region=US&lang=en-US', 'value': 'Q4 Earnings Roundup: Organon (NYSE:OGN) And The Rest Of The Branded Pharmaceuticals Segment'}",MRK,Yahoo Finance,"Q4 Earnings Roundup: Organon (NYSE:OGN) And The Rest Of The Branded Pharmaceuticals Segment Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Organon (NYSE:OGN) and the best and worst performers in the branded pharmaceuticals industry.",2025,4,8,1,342,54,91,13
"The past six months haven’t been great for Merck. It just made a new 52-week low of $79.69, and shareholders have lost 26.6% of their capital. This was partly due to its softer quarterly results and might have investors contemplating their next move.","{'type': 'text/html', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=MRK&region=US&lang=en-US', 'value': 'The past six months haven’t been great for Merck. It just made a new 52-week low of $79.69, and shareholders have lost 26.6% of their capital. This was partly due to its softer quarterly results and might have investors contemplating their next move.'}",f4d6079f-f84f-3c01-bfbd-4dbb8d14b6a4,False,"[{'rel': 'alternate', 'type': 'text/html', 'href': 'https://finance.yahoo.com/news/2-reasons-mrk-1-not-091045372.html?.tsrc=rss'}]",https://finance.yahoo.com/news/2-reasons-mrk-1-not-091045372.html?.tsrc=rss,2025-04-07 09:10:45,"time.struct_time(tm_year=2025, tm_mon=4, tm_mday=7, tm_hour=9, tm_min=10, tm_sec=45, tm_wday=0, tm_yday=97, tm_isdst=0)",2 Reasons to Like MRK (and 1 Not So Much),"{'type': 'text/plain', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=MRK&region=US&lang=en-US', 'value': '2 Reasons to Like MRK (and 1 Not So Much)'}",MRK,Yahoo Finance,"2 Reasons to Like MRK (and 1 Not So Much) The past six months haven’t been great for Merck. It just made a new 52-week low of $79.69, and shareholders have lost 26.6% of their capital. This was partly due to its softer quarterly results and might have investors contemplating their next move.",2025,4,7,0,292,53,41,10
"Big pharmaceutical stocks mostly rose after President Trump’s executive order exempted medicines from new tariffs. Merck, Bristol-Myers Squibb, and Johnson & Johnson were among the top performers in the S&amp;P 500, with the sector also benefiting from its status as a defensive play.","{'type': 'text/html', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=MRK&region=US&lang=en-US', 'value': 'Big pharmaceutical stocks mostly rose after President Trump’s executive order exempted medicines from new tariffs. Merck, Bristol-Myers Squibb, and Johnson & Johnson were among the top performers in the S&amp;P 500, with the sector also benefiting from its status as a defensive play.'}",4d202ae2-292d-33fc-b5df-f9468db0055c,False,"[{'rel': 'alternate', 'type': 'text/html', 'href': 'https://finance.yahoo.com/m/4d202ae2-292d-33fc-b5df-f9468db0055c/pharma-stocks-aren%27t-in-the.html?.tsrc=rss'}]",https://finance.yahoo.com/m/4d202ae2-292d-33fc-b5df-f9468db0055c/pharma-stocks-aren%27t-in-the.html?.tsrc=rss,2025-04-03 14:30:22,"time.struct_time(tm_year=2025, tm_mon=4, tm_mday=3, tm_hour=14, tm_min=30, tm_sec=22, tm_wday=3, tm_yday=93, tm_isdst=0)","Pharma Stocks Aren't in the Clear, Despite Tariff Exemption—Heard on the Street","{'type': 'text/plain', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=MRK&region=US&lang=en-US', 'value': ""Pharma Stocks Aren't in the Clear, Despite Tariff Exemption—Heard on the Street""}",MRK,Yahoo Finance,"Pharma Stocks Aren't in the Clear, Despite Tariff Exemption—Heard on the Street Big pharmaceutical stocks mostly rose after President Trump’s executive order exempted medicines from new tariffs. Merck, Bristol-Myers Squibb, and Johnson & Johnson were among the top performers in the S&amp;P 500, with the sector also benefiting from its status as a defensive play.",2025,4,3,3,364,55,79,12
"As the U.S. stock market experiences volatility amid anticipation of new tariff announcements from President Trump, investors are keenly observing how these trade measures might impact economic growth and inflation. In such an uncertain environment, dividend stocks can offer a measure of stability and income through regular payouts, making them attractive options for those seeking to balance risk with potential returns.","{'type': 'text/html', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=MRK&region=US&lang=en-US', 'value': 'As the U.S. stock market experiences volatility amid anticipation of new tariff announcements from President Trump, investors are keenly observing how these trade measures might impact economic growth and inflation. In such an uncertain environment, dividend stocks can offer a measure of stability and income through regular payouts, making them attractive options for those seeking to balance risk with potential returns.'}",09810720-f67a-30df-96b6-064e3abdd5bc,False,"[{'rel': 'alternate', 'type': 'text/html', 'href': 'https://finance.yahoo.com/news/3-dividend-stocks-consider-yields-170138184.html?.tsrc=rss'}]",https://finance.yahoo.com/news/3-dividend-stocks-consider-yields-170138184.html?.tsrc=rss,2025-04-02 17:01:38,"time.struct_time(tm_year=2025, tm_mon=4, tm_mday=2, tm_hour=17, tm_min=1, tm_sec=38, tm_wday=2, tm_yday=92, tm_isdst=0)",3 Dividend Stocks To Consider With Yields Up To 4.2%,"{'type': 'text/plain', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=MRK&region=US&lang=en-US', 'value': '3 Dividend Stocks To Consider With Yields Up To 4.2%'}",MRK,Yahoo Finance,"3 Dividend Stocks To Consider With Yields Up To 4.2% As the U.S. stock market experiences volatility amid anticipation of new tariff announcements from President Trump, investors are keenly observing how these trade measures might impact economic growth and inflation. In such an uncertain environment, dividend stocks can offer a measure of stability and income through regular payouts, making them attractive options for those seeking to balance risk with potential returns.",2025,4,2,2,476,71,52,10
"The average brokerage recommendation (ABR) for Merck (MRK) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?","{'type': 'text/html', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=MRK&region=US&lang=en-US', 'value': 'The average brokerage recommendation (ABR) for Merck (MRK) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?'}",b5778b70-324e-3c62-9440-c7a0806d39c2,False,"[{'rel': 'alternate', 'type': 'text/html', 'href': 'https://finance.yahoo.com/news/wall-street-analysts-think-merck-133010906.html?.tsrc=rss'}]",https://finance.yahoo.com/news/wall-street-analysts-think-merck-133010906.html?.tsrc=rss,2025-04-02 13:30:10,"time.struct_time(tm_year=2025, tm_mon=4, tm_mday=2, tm_hour=13, tm_min=30, tm_sec=10, tm_wday=2, tm_yday=92, tm_isdst=0)",Wall Street Analysts Think Merck (MRK) Is a Good Investment: Is It?,"{'type': 'text/plain', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=MRK&region=US&lang=en-US', 'value': 'Wall Street Analysts Think Merck (MRK) Is a Good Investment: Is It?'}",MRK,Yahoo Finance,"Wall Street Analysts Think Merck (MRK) Is a Good Investment: Is It? The average brokerage recommendation (ABR) for Merck (MRK) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?",2025,4,2,2,318,49,67,12
"Amazon.com, Oracle and Merck are part of the Zacks top Analyst Blog.","{'type': 'text/html', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=MRK&region=US&lang=en-US', 'value': 'Amazon.com, Oracle and Merck are part of the Zacks top Analyst Blog.'}",2b3a07fc-97b9-37cb-8727-e3dc0bc08ed8,False,"[{'rel': 'alternate', 'type': 'text/html', 'href': 'https://finance.yahoo.com/news/zacks-analyst-blog-highlights-amazon-131400616.html?.tsrc=rss'}]",https://finance.yahoo.com/news/zacks-analyst-blog-highlights-amazon-131400616.html?.tsrc=rss,2025-04-02 13:14:00,"time.struct_time(tm_year=2025, tm_mon=4, tm_mday=2, tm_hour=13, tm_min=14, tm_sec=0, tm_wday=2, tm_yday=92, tm_isdst=0)","The Zacks Analyst Blog Highlights Amazon.com, Oracle and Merck","{'type': 'text/plain', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=MRK&region=US&lang=en-US', 'value': 'The Zacks Analyst Blog Highlights Amazon.com, Oracle and Merck'}",MRK,Yahoo Finance,"The Zacks Analyst Blog Highlights Amazon.com, Oracle and Merck Amazon.com, Oracle and Merck are part of the Zacks top Analyst Blog.",2025,4,2,2,131,21,62,9
"Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), Oracle Corp. (ORCL) and Merck & Co., Inc. (MRK).","{'type': 'text/html', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=MRK&region=US&lang=en-US', 'value': ""Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), Oracle Corp. (ORCL) and Merck & Co., Inc. (MRK).""}",684d4e95-276e-3ca4-bfd4-01e165dd7451,False,"[{'rel': 'alternate', 'type': 'text/html', 'href': 'https://finance.yahoo.com/news/top-analyst-reports-amazon-oracle-205900596.html?.tsrc=rss'}]",https://finance.yahoo.com/news/top-analyst-reports-amazon-oracle-205900596.html?.tsrc=rss,2025-04-01 20:59:00,"time.struct_time(tm_year=2025, tm_mon=4, tm_mday=1, tm_hour=20, tm_min=59, tm_sec=0, tm_wday=1, tm_yday=91, tm_isdst=0)","Top Analyst Reports for Amazon, Oracle & Merck","{'type': 'text/plain', 'language': None, 'base': 'https://feeds.finance.yahoo.com/rss/2.0/headline?s=MRK&region=US&lang=en-US', 'value': 'Top Analyst Reports for Amazon, Oracle & Merck'}",MRK,Yahoo Finance,"Top Analyst Reports for Amazon, Oracle & Merck Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), Oracle Corp. (ORCL) and Merck & Co., Inc. (MRK).",2025,4,1,1,203,32,46,8
